Weight Regain After Stopping Wegovy or Mounjaro: What the Latest Research Shows

New research indicates that individuals may regain a significant portion of the weight lost while using medications like Mounjaro or Wegovy after discontinuing treatment. A recent study published in eClinicalMedicine analyzed data from over 3,200 participants across six clinical trials, revealing important insights into the long-term effects of these medications.

How Much Weight is Typically Regained?

The study found that, on average, participants regained approximately 60% of the weight they had lost within 52 weeks of stopping medication. However, the rate of weight regain slowed over time. After 60 weeks, patients typically regained about 75% of their initial weight loss, meaning roughly 25% of the weight loss may be sustained long-term. Drugs.com provides a side-by-side comparison of Wegovy, and Mounjaro.

The Role of Muscle Mass in Weight Loss and Regain

Experts suggest that a substantial portion of the weight lost during treatment with GLP-1 receptor agonists may be muscle mass – approximately half. This is a critical consideration, as regaining weight primarily as fat could be detrimental to overall health and metabolic balance. If weight regain consists largely of fat, individuals may be in a worse situation than before treatment in terms of fat-muscle balance.

How Do GLP-1 Drugs Work?

Weight loss injections like Mounjaro and Wegovy belong to a class of drugs known as GLP-1 receptor agonists. These medications mimic the effects of the naturally occurring GLP-1 hormone, which regulates blood sugar levels and suppresses appetite, leading to reduced food intake. WebMD explains how these medications work.

Initially developed for the treatment of type 2 diabetes, these drugs have since been approved and utilized for obesity treatment.

What Happens When You Stop Taking the Medication?

Brajan Budini, a study author, explained that these medications suppress appetite and promote feelings of fullness. When the medication is stopped, this effect diminishes, potentially leading to increased appetite and rapid weight regain.

Switching Medications: What Does the Research Say?

Clinical studies suggest that switching from Wegovy to Mounjaro, or from any other GLP-1 medication, may lead to continued weight loss and improved results. PrescriptionDoctor.com details the process and outcomes of switching medications.

Expert Recommendations

Researchers emphasize the importance of preparing for the potential for weight regain if weight loss medications are discontinued. Both doctors and patients should be aware of this risk and discuss strategies for managing it, including lifestyle modifications.

Key Takeaways

• Approximately 60% of weight lost during treatment with Mounjaro or Wegovy may be regained within 52 weeks of stopping the medication.
• Weight regain slows down over time, with approximately 25% of weight loss potentially being sustained long-term.
• A significant portion of weight lost during treatment may be muscle mass, making the composition of regained weight crucial.
• GLP-1 receptor agonists work by mimicking a natural hormone to regulate blood sugar and suppress appetite.
• Preparation and lifestyle changes are essential for managing weight after discontinuing these medications.